From 1 January 2023, the Australian Commission on Safety and Quality in Health Care became the custodian of a range of Quality Use of Medicines (QUM) functions, expanding our role in QUM stewardship.
This report provides analyses of antimicrobial use and appropriateness in the community in 2020 and 2021, with comparison to and trends from 2015.
The Australian Group on Antimicrobial Resistance (AGAR) annually publishes data on antimicrobial resistance (AMR) and epidemiologic and genetic patterns in bloodstream infections in Australia, relating to three main organisms: enterococcal species, Staphylococcus aureus and gram-negative bacteria.
In 2018, the Commission commenced work on behalf of the Australian Government Department of Health (the Department) and all states and territories to deliver the Governance Framework.
Discover how the National Clinical Trials Governance Framework is implemented and assessed for clinical trials in Australia.
The NSQHS Standards support the rights of people with intellectual disability. The Commission has guidance and resources for inclusive health care.